Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer

Semaan, A., Bernard, V., Kim, D. U., Lee, J. J., Huang, J., Kamyabi, N., Stephens, B. M., Qiao, W., Varadhachary, G. R., Katz, M. H., Shen, Y., San Lucas, F. A., Gascoyne, P., Alvarez, H. A., Maitra, A. and Guerrero, P. A.  Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification…

Read More

Safety and efficacy of Wharton’s jelly‐derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: A phase I/IIa study

Shim, J., Kim, K., Kim, K. G., Choi, U., Kyung, J. W., Sohn, S., Lim, S. H., Choi, H., Ahn, T., Choi, H. J., Shin, D. and Han, I.  Safety and efficacy of Wharton’s jelly‐derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: A phase I/IIa study.  STEM CELLS Translational Medicine. 2020.  doi: 10.1002/sctm.20-0308

Read More

Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data

Kerstan, A., Niebergall-Roth, E., Esterlechner, J., Schröder, H. M., Gasser, M., Waaga-Gasser, A. M., Goebeler, M., Rak, K., Schrüfer, P., Endres, S., Hagenbusch, P., Kraft, K., Dieter, K., Ballikaya, S., Stemler, N., Sadeghi, S., Tappenbeck, N., Murphy, G. F., Orgill, D. P., Frank, N. Y., Ganss, C., Scharffetter-Kochanek, K., Frank, M. H. and Kluth, M.…

Read More